As part of its market surveillance efforts, the Food and Drugs Authority (FDA) has found that the antimalarial medicine COMBIART Tablets (Artemether/Lumefrantrine 20/120) is a counterfeit.

The FDA noted in a statement that the medicine samples from the Northern Area were fabricated because they lacked either of the two active medicinal ingredients listed on the label.

The details of the drug are as follows:Batch number:7335119Manufacturing date: 03/2021Expiry date: 02/2024Manufacturer: Strides Arcola LtdNAFDAC Registration: A4-6700

The FDA has therefore entreated health workers and the public to be on the lookout for such drug and report to its outfit should they come into contact with the drug.

ALERT- SUSPECTED FALSIFIED ANTIMALARIAL DRUG ON THE GHANAIAN MARKET. #FDAGhana2023 #FDACommunications pic.twitter.com/bbeAUPH2Ua— FDAGhana (@fdaghana) February 22, 2023

Source: The Independent Ghana